503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.39%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-16.31%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-3.67%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
1.81%
Margin expansion 1.25-1.5x CRWV's 1.30%. Bruce Berkowitz would examine sustainability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.57%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-3.90%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
5.13%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
-6.80%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-2.33%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-8.04%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-2.80%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
11.76%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-7.18%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-1.89%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-1.60%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-9.81%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-4.67%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.81%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-9.81%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.